Berman Tabacco Investigates Potential Securities Claims Against Athira Pharma, Inc. (ATHA)Newsfile Corp • 06/18/21
Athira Pharma Chief Operating Officer, Mark Litton, Assumes Day-to-Day Leadership Responsibilities of CompanyGlobeNewsWire • 06/17/21
Approval of Biogen's drug for Alzheimer's disease may ease path for others such as Athira PharmaGeekWire • 06/07/21
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business HighlightsGlobeNewsWire • 05/13/21
Athira Pharma, Inc. (ATHA) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 04/22/21
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation ForumGlobeNewsWire • 04/21/21
Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair PathwayGlobeNewsWire • 04/08/21
Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business HighlightsGlobeNewsWire • 03/25/21
Athira Pharma Announces Appointment of Barbara Kosacz to its Board of DirectorsGlobeNewsWire • 03/08/21
Athira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences ConferenceGlobeNewsWire • 03/02/21
Athira Pharma Announces Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 02/10/21
Athira Pharma to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/07/21
Athira Pharma Announces Appointment of Kelly A. Romano to its Board of DirectorsGlobeNewsWire • 12/14/20
Athira Pharma wins $15M grant for clinical trial of Alzheimer's drug from National Institute on AgingGeekWire • 12/08/20